Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +10

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +10

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu, Dingyu Zhang, Xingwang Li et al. · New England Journal of Medicine · 2020 · 30.4K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Asymptotically Efficient Rank Invariant Test Procedures

Richard Peto, Julian Peto · Journal of the Royal Statistical Society Series A (General) · 1972 · 3.4K citations

Natural Sciences, Biostatistics, Computer Science +5

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

New England Journal of Medicine · 2022 · 2.2K citations · Full text

Medicine, Infectious Diseases, Pharmacology +12